The cardiovascular needle market in Europe is expected to grow from US$ 24.40 Million in 2021 to US$ 39.26 Million by 2028; it is estimated to grow at a CAGR of 7.0% from 2021 to 2028.
Elderly people are at a high risk of heart diseases due to weakened immunity and other health issues. In general, aging leads to stiffening of heart muscles and blood vessels; moreover, the systolic blood pressure rises with aging. Thus, the people with the age 75 and above commonly suffer from hypertension, which may subsequently cause coronary artery disease and heart failure. According to the United Nation’s World Population Ageing 2017 report, around 962 million people were aged 60 years or above, and the number is expected to reach ~2.1 billion by 2050. The elderly population is known to have an atypical presentation of illness along with comorbidities and unfavourable outcomes. The major reason for the disease is related to age-related structural and functional changes in the cardiovascular system. Thus, the rising geriatric population, coupled with the surge in CVD prevalence among these people, is driving the cardiovascular needles market growth.Cardiac surgery across Europe is being set back as a result of the ongoing coronavirus. Operations are being postponed, treatment delayed, and critical care staff have been redeployed to cope with the impact of the Covid-19 epidemic on health services. While evidence illustrates a significant fall in heart surgery procedures in the United States and in the UK. In England, the charity the British Heart Foundation has monitored the situation and found that around 371,000 heart operations and procedures were performed in 2020, down 22 per cent from 2019 when more than 473,000 were carried out. Operations such as coronary bypass and heart valve surgery fell from 37,000 cases to around 25,000 by the end of November 2020, compared with 2019, while procedures such as fitting stents to open blocked arteries also fell. Meanwhile, research presented at the 57th Annual Meeting of The Society of Thoracic Surgeons showed that in the United States Covid-19 resulted in a 53% decrease nationwide in all adult cardiac surgery. Data from Public Health England show there have been at least 5,700 excess deaths from heart diseases and stroke since the pandemic began. Delays to heart operations and procedures are likely contributing to more deaths than expected.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the cardiovascular needle market. The Europe cardiovascular needle market is expected to grow at a good CAGR during the forecast period.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Europe Cardiovascular Needle Market Segmentation
By Application
- Open Heart Surgery
- Cardiac Valve Procedures
By Usage
- Single Use
- Multiple Uses
By End User
- Hospitals and Clinics
- Ambulatory Surgical Centres
- Cardiovascular Centres
By Country
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Companies Mentioned
- Ethicon (Johnson & Johnson Services, Inc.)
- MANI, INC
- Barber of Sheffield
- FSSB surgical needles GmbH
- Medtronic
- Teleflex Incorporated
- Meril Life Sciences Pvt. Ltd.
- CP Medical
- SMB Corporation of India
Europe Cardiovascular Needle Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 24.40 Million |
Market Size by 2028 | US$ 39.26 Million |
Global CAGR (2021 - 2028) | 7.0% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | Europe
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.















- Ethicon (Johnson & Johnson Services, Inc.)
- MANI, INC
- Barber of Sheffield
- FSSB surgical needles GmbH
- Medtronic
- Teleflex Incorporated
- Meril Life Sciences Pvt. Ltd.
- CP Medical
- SMB Corporation of India


